A drugmaker trialling an autoimmune disease treatment in the UK has become the first cleared to use electronic informed consent by the National Health Service (NHS).
API supplier Hepalink will buy Cytovance for $206m (€183m) in a deal the biologics CDMO says will help expedite its expansion plans.
Shire will use contractors to increase production of Cinryze, the half billion dollar-a-year Hereditary Angioedema (HAE) drug it bought with ViroPharma in 2014.
A CEO for Halo, plus senior appointments at INC Research, Unilife and Certara.
Chiltern’s takeover of Theorem Clinical will be the latest acquisition in a busy eight months of deals impacting the mid-sized CRO space.
Swedish CDMO Recipharm will contract manufacture a three-drug combination antibiotic for emerging Israeli biopharma RedHill.
Merck Millipore says it has closed the Bangalore plant which produced its GeNei brand of biologics manufacturing and R&D supplies.